Pharmacological Approaches to the Identification and Classification of Myometrial Oxytocin Receptors

References

• Pliška V., Heiniger J., Müller-Lhotsky A., Pliska P., Ekberg B. Binding of oxytocin to uterine cells in vitro. Occurence of several binding site populations and reidentification of oxytocin receptors. J. Biol. Chem. 1986; 261: 16984–16989
   PubMed Web of Science ®Google Scholar
• Munsick R. A. Effect of magnesium ion on the response of the rat uterus to neurohypophysial hormones and analogues. Endocrinol. 1960; 66: 451–457
   Web of Science ®Google Scholar
• Pliška V. Dose-response models: similarity with population growth dynamics. Trends in Pharmacol. Sci. (TIPS) 1987; 8: 50–52
   Google Scholar
• Rudinger J., Pliška V., Krejčí I. Oxytocin analogs in the analysis of some phases of hormone action. Rec. Prog. Hormone Res. 1972; 28: 131–166
   Google Scholar
• Pliška V. Pharmacokinetic of neurohypophysial and related peptides: mathematical models. II Farmaco, Ed. Sci. 1968; 23: 623–641
   Google Scholar
• Clark A. J. Heffter's Handbuch der Experimentellen Pharmakologie, Vol. 4: General Pharmacology. Springer-Verlag, Berlin 1937; 61–90
   Google Scholar
• Ariëns E. J., van Rossum J. M., Simonis A. M. A theoretical basis of molecular pharmacology. Arzneim.-Forsch. 1956; 6: 282–293
   Google Scholar
• Stephenson R. P. A modification of receptor theory. Br. J. Pharmac. 1956; 11: 379–393
   PubMed Web of Science ®Google Scholar
• Nickerson M. Receptor occupancy and tissue response. Nature 1956; 178: 697–698
   PubMedGoogle Scholar
• Furchgott R. F. The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. Adv. Drug Res. 1966; 3: 21–55
   Google Scholar
• Lindeberg G., Vilhardt H., Larsson L.-E., Melin P., Pliška V. Effect of O-alkylated analogues of lysine vasopressin on adenylate cyclese of pig kidney membranes. J. Receptor Res. 1980; 1: 389–402
   PubMed Web of Science ®Google Scholar
• Pliška V. Investigation of drug-receptor interactions by means of irreversible receptor inhibitors: binding of oxytocin and angiotensin II to their receptors in rat uterus. J. Receptor Res. 1984; 4: 371–383
   PubMed Web of Science ®Google Scholar
• Krejčí I., Poláček I., Rudinger J. The action of 2–0-methyltyrosine-oxytocin on the rat and rabbit uterus: effect of some experimental conditions on change from agonism to antagonism. Br. J. Pharmac. 1967; 30: 506–517
   Google Scholar
• Krejčí I., Pliška V., Rudinger J. Change from agonism to antagonism in the action of some oxytocin analogues: interpretation by a receptor model. Br. J. Pharmac. 1970; 39: 219P
   Google Scholar
• Rudinger J., Krejčí I., Pliška V., Poláček I. Transition from agonism to antagonism in oxytocin analogues. Naunyn-Schmiedebergs Arch. Pharmak. 1971; 269: 405
   Google Scholar
• Pliška V., Marbach P. Some biological properties of an “irreversible” antagonist of neurohypophyseal hormones, deamino-[Phe(4-CH3CH2CONH)2]-oxytocin, and its isosteric analogue, deamino-[Phe(4-CH3CH2CONH)2]-oxytocin. Eur. J. Pharmacol. 1978; 49: 213–22
   PubMedGoogle Scholar
• Pliška V., Marbach P., Vašák J., Rudinger J. [2-o-Iodotyrosine]-oxytocin and [2-o-methyltyrosine]-oxytocin: basic pharmacology and comments on their potential use in binding studies. Experientia 1977; 33: 367–369
   PubMedGoogle Scholar
• Soloff M. S. Uterine receptors for oxytocin: correlation between antagonist potency and receptor binding. Br. J. Pharmac. 1976; 57: 381–386
   Google Scholar
• Arunlakshana O., Schild H. O. Some quantitative uses of drug antagonists. Br. J. Pharmac. 1959; 14: 48–58
   PubMed Web of Science ®Google Scholar
• Hruby V., Mosberg H. I. Hormone Antagonists, M. K. Agarwal. W. de Gruyter, Berlin 1982; 433–473
   Google Scholar
• Pliška V., Heiniger J. QSAR in Drug Design and Toxicology, D. Hadži, B. Jerman-Blaž. Elsevier, Amsterdam 1987; 263–267
   Google Scholar
• Pliška V. Affinity of 1,2-substituted oxytocin analogues to the uterus receptor: Free-Wilson and Hansch analysis. Experientia 1978; 34: 1190–1192
   PubMedGoogle Scholar
• Free S. M., Wilson J. W. A mathematical contribution to structure-activity studies. J. Med. Chem. 1964; 7: 395–399
   PubMed Web of Science ®Google Scholar
• Berde B., Boissonnas R. A. Handbook of Experimental Pharmacology, Vol XXIII: Neurohypophysial Hormones and Similar Polypeptides, B. Berde. Springer-Verlag, Berlin 1968; 802–870
   Google Scholar
• Furchgott R. F., Bursztyn P. Comparison of dissociation constants and of relative efficacies of selected agonists acting on parasympathetic receptors. Ann. N.Y. Acad Sci. 1967; 144: 882–899
   Web of Science ®Google Scholar
• Soloff M. S. Uterine receptors for oxytocin: effects of estrogen. Biochem. Biophys. Res. Commun. 1975; 65: 205–212
   Google Scholar
• Riemer R. K., Goldfien A. C., Goldfien A., Roberts J. M. Rabbit uterine oxytocin receptors and in vitro contractile response: abrupt changes at term and the role of eicosanoids. Endocrinol. 1986; 119: 699–709
   PubMedGoogle Scholar
• Fuchs A.-R., Fuchs F., Husslein P., Soloff M. S., Fernstrom M. J. Oxytocin receptors and human parturition: a dual role for oxytocin in initiation of labor. Science 1982; 215: 1396–1398
   PubMed Web of Science ®Google Scholar